Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Celunol was a pioneering industrial biotechnology company focused on the development and commercialization of cellulosic ethanol from non-food biomass. Originally founded as BC International, the company utilized proprietary recombinant microorganisms and enzymatic processes to convert agricultural residues and wood waste into renewable fuel. In 2007, Celunol merged with Diversa Corporation to form Verenium Corporation, creating a vertically integrated leader in the biofuels sector. The company's technology was notably demonstrated at a commercial-scale facility in Jennings, Louisiana, which was the first of its kind in the United States. Following the merger, the combined entity's assets were eventually acquired by BASF in 2013, integrating Celunol's innovations into a global industrial biosolutions portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Celunol.